Caribou Biosciences
Founded
2011
2011
Geography
United States of America based
United States of America based
Funding
$74.600 M
$74.600 M
Caribou Biosciences is a pioneer in the revolutionary field of CRISPR-Cas genome editing. Our proprietary technology puts us at the forefront of the development of new medical therapies and bio-based products which offer profound benefits to both human health and society as a whole.
Technologies
CRISPR Startups Gene Therapy StartupsR&D Platform
Pipelines
No pipelines published yet
Products
Services
No services posted yet